UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000010567 |
|---|---|
| Receipt number | R000012359 |
| Scientific Title | Usability testing of Minodoronate 50mg for secondary osteoporosis in prostatic caricnoma patients |
| Date of disclosure of the study information | 2013/05/01 |
| Last modified on | 2017/08/04 12:47:18 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Usability testing of Minodoronate 50mg for secondary osteoporosis in prostatic caricnoma patients
Acronym
Minodonate for prostatic carcinoma
Scientific Title
Usability testing of Minodoronate 50mg for secondary osteoporosis in prostatic caricnoma patients
Scientific Title:Acronym
Minodonate for prostatic carcinoma
Region
| Japan |
Condition
Condition
secondary osteoporosis in prostatic carcinoma patients
Classification by specialty
| Endocrinology and Metabolism | Urology | Adult |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To prevent secondary osteoporosis in prostatic carcinoma patients using Minodoronate
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Phase II
Assessment
Primary outcomes
BMD
Key secondary outcomes
PSA,ICTP,BAP
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Medicine |
Interventions/Control_1
medical presence of Minodoronate
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male
Key inclusion criteria
prostatic carcinoma patients just start hormonal treatments
Key exclusion criteria
patients using bisphosphonates
patients with secondary osteoporosis which cause is not prostatic carcinoma
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Isao KURODA |
Organization
Tokyo Medical University,Ibaraki Medical Center
Division name
Urology
Zip code
Address
3-20-1,Cyuo,Ami,Ibaraki,Japan
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Isao KURODA |
Organization
Tokyo Medical University,Ibaraki Medical Center
Division name
Urology
Zip code
Address
3-20-1,Cyuo,Ami,Ibaraki,Japan
TEL
0298871161
Homepage URL
veq01625@tokyo-med.ac.jp
Sponsor or person
Institute
Urology,Tokyo Medical University,Ibaraki Medical Center
Institute
Department
Personal name
Funding Source
Organization
Urology,Tokyo Medical University,Ibaraki Medical Center
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
東京医科大学茨城医療センター泌尿器科
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 05 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2013 | Year | 04 | Month | 23 | Day |
Date of IRB
Anticipated trial start date
| 2013 | Year | 05 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2013 | Year | 04 | Month | 23 | Day |
Last modified on
| 2017 | Year | 08 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012359
